Enoxaparin sodium_Enoxaparin sodium_Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

中



Home
About us
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. was founded in 2000. On 19 August 2011, the company was listed on the Growth Enterprise Market of Shenzhen Stock Exchange (stock code: 300255)
News
- Company news
Development of Changshan Pharmaceutical has been timely and accurately recorded and understood from a unique perspective.
Products
APIs, preparations, and products under research. The company is a biochemical pharmaceutical enterprise integrating research, development, production, sales and import and export trade.
Investor relations
- Interactive platform
- Company announcement
At present, the registered capital is RMB 935 million yuan and the total assets are RMB 3.5 billion yuan. It has four production bases, nine subsidiaries, two overseas companies and two joint ventures.
Human resources
- Talent concept
Changshan Pharmaceutical regards talent as the company’s first resource and relies on “revitalizing the enterprise through talents” as the company’s human resources development strategy.
Subsidiary
Contact us

Product Display

Enoxaparin sodium

[ Grade ] : Injectable

[ Product capacity ] : 5000kgs per year

[ Specification ] : EP/USP/BP/IP
[Packaging ] : 5kgs/tin

Share： 

时间：

地点：